Literature DB >> 26673997

Relation of Paraoxonase1, Arylesterase and Lipid Profile in Ischemic Stroke Patients.

Seema Sanjay Chawhan1, Mukund R Mogarekar2, Reena V Wagh3, Rajkumar R Das4, Sanjay S Pramanik1, Sanjay M Sonune5, Sanjay M Chawhan6.   

Abstract

BACKGROUND: Paraoxonase 1 (PON1) is an enzyme associated with High density lipoprotein (HDL) in blood and it is considered to have antioxidant and antiatherogenic properties. PON1 plays an important role in protecting HDL and especially low density lipoprotein (LDL) from oxidative modification by hydrolyzing lipid peroxides which are known to be associated with many vascular diseases including atherosclerosis and ischemic stroke. AIM: The aim of the study was to evaluate and correlate serum paraoxonase (PON1) and arylesterase (ARE) activities as well as lipid profile levels in patients with ischemic stroke.
MATERIALS AND METHODS: The study population was comprised of 50 ischemic stroke patients and 50 healthy controls. The serum PON1 and ARE activities were measured spectrophotometrically by using paraoxon and phenylacetate as substrate respectively by Eckerson method. Serum lipid was measured using routine biochemical method.
RESULTS: The normality of the distribution of the parameters are assessed by Shapiro-Wilk test. Two sample t-test is applied for hypothesis testing. The serum PONI and arylesterase ARE decreased significantly in ischemic stroke patients (p<0.001). The PON1 was positively correlated with HDL.
CONCLUSION: This study strongly suggests that the estimation of HDL-C associated PON1 enzyme gives valuable information for prediction of risk of ischemic stroke due to cerebrovascular thromboembolism. The result shows that PON1 and ARE could be considered as a risk factors for ischemic stroke.

Entities:  

Keywords:  Atherosclerosis; HDL; LDL oxidation; Paraoxon

Year:  2015        PMID: 26673997      PMCID: PMC4668397          DOI: 10.7860/JCDR/2015/15345.6707

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  21 in total

1.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

2.  Enzymatic determination of total cholesterol in serum.

Authors:  P Roeschlau; E Bernt; W Gruber
Journal:  Z Klin Chem Klin Biochem       Date:  1974-05

3.  Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities.

Authors:  Dragomir I Draganov; John F Teiber; Audrey Speelman; Yoichi Osawa; Roger Sunahara; Bert N La Du
Journal:  J Lipid Res       Date:  2005-03-16       Impact factor: 5.922

Review 4.  HDL, its enzymes and its potential to influence lipid peroxidation.

Authors:  M I Mackness; P N Durrington
Journal:  Atherosclerosis       Date:  1995-06       Impact factor: 5.162

5.  Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

Authors:  M Aviram; M Rosenblat; C L Bisgaier; R S Newton; S L Primo-Parmo; B N La Du
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

6.  Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity.

Authors:  R C Sorenson; C L Bisgaier; M Aviram; C Hsu; S Billecke; B N La Du
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-09       Impact factor: 8.311

Review 7.  Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development.

Authors:  Michael Aviram; Mira Rosenblat
Journal:  Free Radic Biol Med       Date:  2004-11-01       Impact factor: 7.376

8.  Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.

Authors:  M Burstein; H R Scholnick; R Morfin
Journal:  J Lipid Res       Date:  1970-11       Impact factor: 5.922

9.  Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R.

Authors:  M Aviram; S Billecke; R Sorenson; C Bisgaier; R Newton; M Rosenblat; J Erogul; C Hsu; C Dunlop; B La Du
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-10       Impact factor: 8.311

10.  Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans.

Authors:  No Soo Kim; Kyungwon Kang; Min Ho Cha; Bong-Joo Kang; Jinseok Moon; Byoung Kab Kang; Byeong-Chan Yu; Yoon-Sik Kim; Sun Mi Choi; Ok-Sun Bang
Journal:  Biochem Biophys Res Commun       Date:  2007-10-04       Impact factor: 3.575

View more
  3 in total

1.  Proteomics-Based Approach to Identify Novel Blood Biomarker Candidates for Differentiating Intracerebral Hemorrhage From Ischemic Stroke-A Pilot Study.

Authors:  David Malicek; Ilka Wittig; Sebastian Luger; Christian Foerch
Journal:  Front Neurol       Date:  2021-12-17       Impact factor: 4.003

2.  Joint Effects of PON1 Polymorphisms and Vegetable Intake on Ischemic Stroke: A Family-Based Case Control Study.

Authors:  Juan Juan; Xia Jiang; Xun Tang; Yiqun Wu; Kexin Sun; Xiao Xiang; Yaohua Tian; Tao Wu; Qi Sun; Peter Kraft; Yonghua Hu
Journal:  Int J Mol Sci       Date:  2017-12-07       Impact factor: 5.923

Review 3.  Search for Reliable Circulating Biomarkers to Predict Carotid Plaque Vulnerability.

Authors:  Núria Puig; Elena Jiménez-Xarrié; Pol Camps-Renom; Sonia Benitez
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.